Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Actinogen Medical.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s Powerplays: Health stocks strap in for a ‘skittish’ ride
News
Top 10 at 10: The most gorgeous ASX stocks in early trade
Health & Biotech
ASX Health Stocks: ACCC gives the OK for API takeover by Wesfarmers
Health & Biotech
ASX Health Stocks: dorsaVi gets ISO certification; Actinogen to begin Phase 2 trial
News
Winners List: Here are the top 100 ASX small cap stocks for 2021
Health & Biotech
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
Health & Biotech
ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results
News
Closing Bell: ASX makes up lost ground, still finishes 0.54% down
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
Health & Biotech
ASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatment
News
10 at 10: These ASX stocks are the most imposing this morning
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
Health & Biotech
Check Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impress
Health & Biotech
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough
Health & Biotech
ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips
Health & Biotech
These two ASX brain health stocks, boosted by FDA’s approval of Adulhelm, are kicking off clinical trials
Health & Biotech